Activity impairment and work productivity loss at baseline and over 24 and 104 weeks by treatment group.
dataset
posted on 2023-11-16, 18:37 authored by Wesley T. Beaulieu, Maureen G. Maguire, Andrew N. AntoszykActivity impairment and work productivity loss at baseline and over 24 and 104 weeks by treatment group.
History
Usage metrics
Keywords
xlink "> participantsreported outcome measuresrandomized controlled trialrandomized clinical trialproliferative diabetic retinopathyless activity impairmentactivity impairment questionnairework productivity lossvitreous hemorrhage dueadjusted mean differenceactivity impairmentwork productivityvitreous hemorrhageadjusted differencevisual recoverytreated initiallystatistically significantsecondary outcomespanretinal photocoagulationmean reductionmean changemain outcomesdescribe patientaverage rateaflibercept group43 ).39 sites30 %)28 %)25 %)23 %)105 ).104 weeks06 );02 );
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC